PharmStockPharmacy Stock

Vastarel
Vastarel

1.4
Formulated to alleviate coronary myocardial ischemia to support cardiac oxygen efficiency and target stable angina.
Ingredient
Trimetazidine
Category
Heart & Blood Pressure
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Trimetazidine dihydrochloride
Reference Brand
Trimetazidine
Product Origin
Generic Brand
Product Manufacturer
Servier
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antihypertensives
Product Category
Anti-Ischemic Agent
Pharmacological Class
Fatty Acid Oxidation Inhibitor
Clinical Indications
Angina pectoris stable
Manufacturer Description
Formulated to alleviate coronary myocardial ischemia to support cardiac oxygen efficiency and target stable angina.
Mechanism of Action
Blocks long-chain 3-ketoacyl-CoA thiolase, shifting myocardial metabolism from fatty acid to glucose oxidation to preserve energy.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
12–24 hours
Contraindications
Parkinson's disease, Uncontrolled extrapyramidal symptoms, Severe renal failure
Severe Adverse Events
Drug-induced parkinsonism — requires immediate medical attention
Common Side Effects
Nausea, Headache, Dizziness
Uncommon Side Effects
Indigestion, Mild rash, Diarrhea
Pregnancy Safety Warnings
TGA Category C: Use if potential benefits outweigh risks. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Ranexa
Information related to Vastarel is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to order Male Pattern Baldness Medication - Regaine Australia